Abstract
The pharmaceutical industry is focusing on developing simple and economical formulations to meet desired drug delivery challenges. Tablet continues to be the most popular dosage form. From the manufacturing point of view tablets can be produced at much higher rate than any other dosage forms. The formulation of tablet must be optimized to achieve desired goals. Poor flow of active pharmaceutical ingredient may raise issues like loss of tablet hardness and weight variation. This may restrict the formulator to use granulation techniques or higher levels of lubricants and glidants to impart the flow, which may adversely affect dissolution and compaction. Furosemide is a class IV drug from BCS classification and possesses poor flow properties. The main objective of study was to improve the flow properties of furosemide and thereby improve its solubility leading ultimately improvements in its bioavailability. We used two different techniques of spherical crystallization to improve the flow properties of furosemide. Our results reveal that the spherical crystallization by neutralization technique is better method than wet spherical crystallization to improve the flow properties of furosemide. Flow properties of excipients also affect the compression process. In conclusion, spherical crystallization technique could be used to enhance the flow properties of furosemide.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Pharmaceutical Sciences and Nanotechnology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.